1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
TABLE 1 INCLUSIONS & EXCLUSIONS 32
1.3 STUDY SCOPE 32
FIGURE 1 SLEEP APNEA ORAL APPLIANCES MARKET SCOPE 32
1.3.1 YEARS CONSIDERED 33
1.4 CURRENCY CONSIDERED 33
1.5 STAKEHOLDERS 33
1.6 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 2 SLEEP APNEA ORAL APPLIANCES MARKET: RESEARCH DESIGN METHODOLOGY 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
FIGURE 3 PRIMARY SOURCES 38
2.1.3 KEY INDUSTRY INSIGHTS 39
2.1.3.1 Key data from primary sources 39
2.1.3.2 Breakdown of primary interviews 40
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
2.2.1 BOTTOM-UP APPROACH 41
2.2.1.1 Approach 1: Company revenue estimation approach 41
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 41
2.2.1.2 Approach 2: Presentations of companies and primary interviews 41
2.2.1.3 Approach 3: Patient-based approach 41
FIGURE 6 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS 42
2.2.1.4 Growth forecast 42
2.2.1.5 CAGR projections 42
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 42
2.2.2 TOP-DOWN APPROACH 43
FIGURE 8 SLEEP APNEA ORAL APPLIANCES MARKET: TOP-DOWN APPROACH 43
2.3 DATA TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.4 RESEARCH ASSUMPTIONS 45
2.5 LIMITATIONS AND RISK ASSESSMENT 45
TABLE 2 RISK ASSESSMENT: SLEEP APNEA ORAL APPLIANCES MARKET 46
2.6 IMPACT OF RECESSION ON SLEEP APNEA ORAL APPLIANCES MARKET 46
3 EXECUTIVE SUMMARY 47
FIGURE 10 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 47
FIGURE 11 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2023 VS. 2028 (USD MILLION) 48
FIGURE 12 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2023 VS. 2028 (USD MILLION) 48
FIGURE 13 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2023 VS. 2028 (USD MILLION) 49
FIGURE 14 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2023 VS. 2028 (USD MILLION) 50
FIGURE 15 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 50
FIGURE 16 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION, 2023 VS. 2028 (USD MILLION) 51
4 PREMIUM INSIGHTS 52
4.1 SLEEP APNEA ORAL APPLIANCES MARKET OVERVIEW 52
FIGURE 17 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE MARKET FOR SLEEP APNEA ORAL APPLIANCES 52
4.2 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION (2023–2028) 53
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 53
4.3 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT AND COUNTRY (2021) 54
FIGURE 19 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SLEEP APNEA ORAL APPLIANCES MARKET IN 2022 54
4.4 SLEEP APNEA ORAL APPLIANCES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
FIGURE 20 COUNTRIES IN ASIA PACIFIC TO GROW AT HIGHER RATES DURING FORECAST PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 21 SLEEP APNEA ORAL APPLIANCES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
5.2.1 DRIVERS 57
5.2.1.1 Large pool of undiagnosed sleep apnea patients 57
TABLE 3 PREVALENCE OF SLEEP APNEA IN 2020 57
5.2.1.2 Growing awareness of effects of untreated sleep apnea 58
TABLE 4 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA 58
5.2.1.3 Growing usage of oral appliances 59
TABLE 5 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SLEEP APNEA 59
5.2.2 RESTRAINTS 59
5.2.2.1 High prices of customized oral appliances 59
5.2.2.2 Alternative therapies and medications 60
5.2.2.3 Risks associated with oral appliance therapy for obstructive sleep apnea 60
5.2.3 OPPORTUNITIES 60
5.2.3.1 Growing demand for home sleep apnea tests 60
5.2.3.2 Increasing focus on telemedicine, mHealth, and AI 61
5.2.3.3 Poor compliance associated with CPAP 62
5.2.4 CHALLENGES 63
5.2.4.1 Complex referral pathways and long waiting periods 63
5.3 PRICING ANALYSIS 63
TABLE 6 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL APPLIANCES 63
5.4 VALUE CHAIN ANALYSIS 63
FIGURE 22 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 64
5.5 SUPPLY CHAIN ANALYSIS 64
FIGURE 23 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES 65
5.6 PORTER’S FIVE FORCES ANALYSIS 65
5.6.1 THREAT OF NEW ENTRANTS 66
5.6.2 THREAT OF SUBSTITUTES 66
5.6.3 BARGAINING POWER OF SUPPLIERS 66
5.6.4 BARGAINING POWER OF BUYERS 66
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 66
5.7 ECOSYSTEM ANALYSIS 67
FIGURE 24 SLEEP APNEA ORAL APPLIANCES MARKET: ECOSYSTEM ANALYSIS 67
5.7.1 ROLE IN ECOSYSTEM 67
FIGURE 25 KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET ECOSYSTEM 68
5.8 REGULATORY ANALYSIS 68
TABLE 7 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING SLEEP APNEA DEVICES 68
5.8.1 NORTH AMERICA 69
5.8.1.1 US 69
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 69
5.8.1.2 Canada 70
TABLE 9 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 70
5.8.2 EUROPE 71
5.8.3 ASIA PACIFIC 71
5.8.3.1 Japan 71
TABLE 10 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 71
5.8.3.2 China 72
TABLE 11 CHINA: CLASSIFICATION OF MEDICAL DEVICES 72
5.8.3.3 India 73
5.8.3.4 Australia 73
5.9 PATENT ANALYSIS 74
5.9.1 PATENT TRENDS FOR SLEEP APNEA ORAL APPLIANCES 74
FIGURE 26 PATENT TRENDS FOR SLEEP APNEA ORAL APPLIANCES, JANUARY 2011–OCTOBER 2023 74
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 74
FIGURE 27 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR SLEEP APNEA ORAL APPLIANCE PATENTS, JANUARY 2011—OCTOBER 2023 75
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 75
5.10.1 REVENUE SHIFT & REVENUE POCKETS FOR SLEEP APNEA ORAL APPLIANCE MANUFACTURERS 75
FIGURE 28 REVENUE SHIFT FOR SLEEP APNEA ORAL APPLIANCES 75
5.11 KEY CONFERENCES & EVENTS IN 2023–2024 76
TABLE 12 SLEEP APNEA ORAL APPLIANCES MARKET: DETAILED LIST OF CONFERENCES & EVENTS 76
5.12 TECHNOLOGY ANALYSIS 77
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 77
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 77
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA ORAL APPLIANCES 77
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA ORAL APPLIANCES (%) 78
5.13.2 BUYING CRITERIA 78
FIGURE 30 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA ORAL APPLIANCES 78
TABLE 14 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA ORAL APPLIANCES 78
5.14 TRADE ANALYSIS 79
TABLE 15 IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018–2022 (USD MILLION) 79
TABLE 16 EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018–2022 (USD MILLION) 79
6 END-USER PERCEPTION ANALYSIS 80
6.1 BENEFITS AND LIMITATIONS OF CURRENT PRODUCT TYPES 80
6.2 BUYING DECISION-MAKING PROCESS 81
6.2.1 INTRODUCTION 81
6.2.1.1 Need recognition 81
6.2.1.2 Gathering information 81
6.2.1.3 Evaluating alternatives 81
6.2.1.3.1 Product features: comparative assessment 82
6.2.1.4 Need gap analysis 83
7 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT 84
7.1 INTRODUCTION 85
TABLE 17 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 85
7.2 MANDIBULAR ADVANCEMENT DEVICES 85
TABLE 18 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 19 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 86
7.2.1 READY-MADE MANDIBULAR ADVANCEMENT DEVICES 87
7.2.1.1 Low cost of readymade MADS to drive demand 87
TABLE 20 READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 87
7.2.2 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES 87
7.2.2.1 Increasing efficacy of custom-made MADs to drive market growth 87
TABLE 21 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 88
7.3 TONGUE-RETAINING DEVICES 88
7.3.1 LOWER SUCCESS RATE OF TRDS TO CHALLENGE MARKET GROWTH 88
TABLE 22 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 89
7.4 DAYTIME-NIGHTTIME APPLIANCES 89
7.4.1 HIGHER COMFORT OF DNAS TO DRIVE ADOPTION 89
TABLE 23 DAYTIME-NIGHTTIME APPLIANCES MARKET, BY REGION, 2021–2028 (USD MILLION) 89
8 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER 90
8.1 INTRODUCTION 91
TABLE 24 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 91
8.2 MALES 91
8.2.1 HIGHER PREVALENCE OF OSA IN MALES TO BOOST MARKET GROWTH 91
TABLE 25 SLEEP APNEA ORAL APPLIANCES MARKET FOR MALES, BY REGION, 2021–2028 (USD MILLION) 92
8.3 FEMALES 92
8.3.1 OSA UNDERDIAGNOSIS IN FEMALES TO RESTRICT MARKET GROWTH 92
TABLE 26 SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALES, BY REGION, 2021–2028 (USD MILLION) 92
9 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE 93
9.1 INTRODUCTION 94
TABLE 27 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 94
9.2 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES 94
9.2.1 FAILURE OF CPAP THERAPY TO DRIVE DEMAND FOR PHYSICIAN-PRESCRIBED ORAL APPLIANCES 94
TABLE 28 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET, BY REGION, 2021–2028 (USD MILLION) 95
9.3 ONLINE OTC ORAL APPLIANCES 95
9.3.1 LACK OF REGULATORY APPROVAL TO HINDER MARKET GROWTH 95
TABLE 29 ONLINE OTC ORAL APPLIANCES MARKET, BY REGION, 2021–2028 (USD MILLION) 96
10 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP 97
10.1 INTRODUCTION 98
TABLE 30 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 98
10.2 BELOW 40 YEARS 98
10.2.1 LOWER PREVALENCE OF SLEEP APNEA IN YOUNGER AGE GROUPS TO RESTRICT MARKET GROWTH 98
TABLE 31 SLEEP APNEA ORAL APPLIANCES MARKET FOR BELOW 40 AGE GROUP, BY REGION, 2021–2028 (USD MILLION) 99
10.3 40–60 YEARS 99
10.3.1 LIFESTYLE FACTORS TO CONTRIBUTE TO MARKET GROWTH 99
TABLE 32 SLEEP APNEA ORAL APPLIANCES MARKET FOR 40–60 AGE GROUP, BY REGION, 2021–2028 (USD MILLION) 99
10.4 ABOVE 60 YEARS 100
10.4.1 INCREASING BREATHING DISTURBANCES AND SLEEP APNEA TO IMPACT MARKET GROWTH 100
TABLE 33 PREVALENCE OF SLEEP APNEA, BY AGE GROUP 100
TABLE 34 SLEEP APNEA ORAL APPLIANCES MARKET FOR ABOVE 60 AGE GROUP, BY REGION, 2021–2028 (USD MILLION) 100
11 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL 101
11.1 INTRODUCTION 102
TABLE 35 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 102
11.2 ONLINE PHARMACIES 102
11.2.1 GROWING PREFERENCE FOR DIRECT DISTRIBUTION CHANNELS TO DRIVE MARKET 102
TABLE 36 SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY REGION, 2021–2028 (USD MILLION) 103
11.3 RETAIL PHARMACIES 103
11.3.1 EASY ACCESS TO PRODUCTS TO BOOST MARKET 103
TABLE 37 SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY REGION, 2021–2028 (USD MILLION) 103
11.4 HOSPITAL PHARMACIES & DENTAL CLINICS 104
11.4.1 HIGH PATIENT CONVENIENCE IN HOSPITAL PHARMACIES TO DRIVE DEMAND 104
TABLE 38 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY REGION, 2021–2028 (USD MILLION) 104
12 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER 105
12.1 INTRODUCTION 106
TABLE 39 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 106
12.2 HOME CARE SETTINGS/INDIVIDUALS 106
12.2.1 RISING PATIENT PREFERENCE FOR ADVANCED HOME SLEEP CARE DEVICES TO DRIVE MARKET 106
TABLE 40 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2021–2028 (USD MILLION) 107
12.3 HOSPITALS 107
12.3.1 RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE DEMAND FOR ORAL APPLIANCES IN HOSPITALS 107
TABLE 41 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 108
12.4 DENTAL CLINICS 108
12.4.1 RISING NUMBER OF DENTAL CLINICS TO BOOST MARKET GROWTH 108
TABLE 42 SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS, BY REGION, 2021–2028 (USD MILLION) 108
13 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION 109
13.1 INTRODUCTION 110
TABLE 43 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION, 2021–2028 (USD MILLION) 110
13.2 NORTH AMERICA 110
13.2.1 NORTH AMERICA: RECESSION IMPACT 111
FIGURE 31 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET SNAPSHOT 111
TABLE 44 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 45 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 112
TABLE 46 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 47 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 113
TABLE 48 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 113
TABLE 49 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 113
TABLE 50 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 114
TABLE 51 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 114
13.2.2 US 114
13.2.2.1 US to dominate North American market during forecast period 114
TABLE 52 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 115
TABLE 53 US: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 54 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 116
TABLE 55 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 116
TABLE 56 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 116
TABLE 57 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 117
TABLE 58 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 117
13.2.3 CANADA 117
13.2.3.1 Large pool of undiagnosed patients to drive market growth. 117
TABLE 59 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 118
TABLE 60 CANADA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 61 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 118
TABLE 62 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 119
TABLE 63 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 119
TABLE 64 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 119
TABLE 65 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 120
13.3 EUROPE 120
13.3.1 EUROPE: RECESSION IMPACT 120
TABLE 66 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 67 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 121
TABLE 68 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 69 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 122
TABLE 70 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 122
TABLE 71 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 123
TABLE 72 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 123
TABLE 73 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 123
13.3.2 GERMANY 124
13.3.2.1 High prevalence of OSA in Germany to boost market 124
TABLE 74 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 124
TABLE 75 GERMANY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 76 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 125
TABLE 77 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 125
TABLE 78 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 126
TABLE 79 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 126
TABLE 80 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 126
13.3.3 FRANCE 127
13.3.3.1 Rising geriatric population to increase incidence of sleep apnea in France 127
TABLE 81 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 127
TABLE 82 FRANCE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 83 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 128
TABLE 84 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 128
TABLE 85 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 129
TABLE 86 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 129
TABLE 87 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 129
13.3.4 UK 130
13.3.4.1 Rising awareness initiatives and sleep service groups to support market growth in UK 130
TABLE 88 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 89 UK: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 90 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 131
TABLE 91 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 131
TABLE 92 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 132
TABLE 93 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 132
TABLE 94 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 132
13.3.5 ITALY 133
13.3.5.1 Growing sleep disorder patient population to drive demand for oral appliances in Italy 133
TABLE 95 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 133
TABLE 96 ITALY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 97 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 134
TABLE 98 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 134
TABLE 99 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 135
TABLE 100 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 135
TABLE 101 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 135
13.3.6 SPAIN 136
13.3.6.1 Low social awareness about sleep apnea and treatment options to challenge market growth 136
TABLE 102 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 103 SPAIN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 104 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 137
TABLE 105 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 137
TABLE 106 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 137
TABLE 107 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 138
TABLE 108 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 138
13.3.7 REST OF EUROPE 138
TABLE 109 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 139
TABLE 110 REST OF EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 111 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 139
TABLE 112 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 140
TABLE 113 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 140
TABLE 114 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 140
TABLE 115 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 141
13.4 ASIA PACIFIC 141
13.4.1 ASIA PACIFIC: RECESSION IMPACT 141
FIGURE 32 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET SNAPSHOT 142
TABLE 116 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 117 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 143
TABLE 118 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 119 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 143
TABLE 120 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 144
TABLE 121 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 144
TABLE 122 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 144
TABLE 123 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 145
13.4.2 JAPAN 145
13.4.2.1 Poor reimbursement scenario in Japan to restrain market growth 145
TABLE 124 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 146
TABLE 125 JAPAN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 126 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 146
TABLE 127 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 147
TABLE 128 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 147
TABLE 129 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 147
TABLE 130 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 148
13.4.3 CHINA 148
13.4.3.1 Increasing diagnostics market in China to raise demand for appliances. 148
TABLE 131 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 149
TABLE 132 CHINA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 133 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 149
TABLE 134 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 150
TABLE 135 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 150
TABLE 136 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 150
TABLE 137 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 151
13.4.4 AUSTRALIA 151
13.4.4.1 Rising number of domestic manufacturers of oral appliances to drive demand in Australia 151
TABLE 138 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 151
TABLE 139 AUSTRALIA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 140 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 152
TABLE 141 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 152
TABLE 142 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 153
TABLE 143 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 153
TABLE 144 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 153
13.4.5 REST OF ASIA PACIFIC 154
TABLE 145 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 154
TABLE 146 REST OF ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 147 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 155
TABLE 148 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 155
TABLE 149 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 156
TABLE 150 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 156
TABLE 151 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 156
13.5 REST OF THE WORLD 157
13.5.1 LATIN AMERICA: RECESSION IMPACT 157
13.5.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 157
TABLE 152 REST OF THE WORLD: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 158
TABLE 153 REST OF THE WORLD: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 154 REST OF THE WORLD: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021–2028 (USD MILLION) 158
TABLE 155 REST OF THE WORLD: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021–2028 (USD MILLION) 159
TABLE 156 REST OF THE WORLD: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 159
TABLE 157 REST OF THE WORLD: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION) 159
TABLE 158 REST OF THE WORLD: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021–2028 (USD MILLION) 160
14 COMPETITIVE LANDSCAPE 161
14.1 OVERVIEW 161
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 161
TABLE 159 OVERVIEW OF STRATEGIES ADOPTED BY KEY SLEEP APNEA ORAL APPLIANCE MANUFACTURERS 161
14.3 REVENUE ANALYSIS 162
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS 162
14.4 MARKET SHARE ANALYSIS 163
FIGURE 34 MARKET SHARE ANALYSIS, 2022 163
14.5 COMPANY EVALUATION MATRIX 164
14.5.1 STARS 164
14.5.2 EMERGING LEADERS 164
14.5.3 PERVASIVE PLAYERS 164
14.5.4 PARTICIPANTS 164
FIGURE 35 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY EVALUATION MATRIX 165
14.5.5 COMPANY FOOTPRINT ANALYSIS 165
TABLE 160 COMPANY FOOTPRINT 165
TABLE 161 COMPANY PRODUCT FOOTPRINT 166
TABLE 162 COMPANY REGIONAL FOOTPRINT 167
14.6 START-UP/SME EVALUATION MATRIX 168
14.6.1 PROGRESSIVE COMPANIES 168
14.6.2 RESPONSIVE COMPANIES 168
14.6.3 DYNAMIC COMPANIES 168
14.6.4 STARTING BLOCKS 168
FIGURE 36 SLEEP APNEA ORAL APPLIANCES MARKET: START-UP/SME EVALUATION MATRIX 169
14.6.5 COMPETITIVE BENCHMARKING 169
TABLE 163 SLEEP APNEA ORAL APPLIANCES MARKET: DETAILED LIST OF KEY START-UPS/SMES 169
14.7 COMPETITIVE SCENARIO 170
14.7.1 PRODUCT LAUNCHES & APPROVALS 170
TABLE 164 SLEEP APNEA ORAL APPLIANCES MARKET: PRODUCT LAUNCHES & APPROVALS, 2020–2023 170
14.7.2 DEALS 170
TABLE 165 SLEEP APNEA ORAL APPLIANCES MARKET: DEALS, 2020–2023 170
14.7.3 OTHER DEVELOPMENTS 171
TABLE 166 SLEEP APNEA ORAL APPLIANCES MARKET: OTHER DEVELOPMENTS, 2020–2023 171
15 COMPANY PROFILES 172
(Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses & competitive threats) *
15.1 KEY PLAYERS 172
15.1.1 SOMNOMED 172
TABLE 167 SOMNOMED: BUSINESS OVERVIEW 172
FIGURE 37 SOMNOMED: COMPANY SNAPSHOT (2023) 173
15.1.2 RESMED 175
TABLE 168 RESMED: BUSINESS OVERVIEW 175
FIGURE 38 RESMED: COMPANY SNAPSHOT (2023) 176
15.1.3 PROSOMNUS SLEEP TECHNOLOGIES 178
TABLE 169 PROSOMNUS SLEEP TECHNOLOGIES: BUSINESS OVERVIEW 178
FIGURE 39 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2022) 178
15.1.4 WHOLE YOU, INC. 180
TABLE 170 WHOLE YOU, INC.: BUSINESS OVERVIEW 180
15.1.5 VIVOS THERAPEUTICS, INC. 182
TABLE 171 VIVOS THERAPEUTICS, INC.: BUSINESS OVERVIEW 182
FIGURE 40 VIVOS THERAPEUTICS, INC.: COMPANY SNAPSHOT (2022) 183
15.1.6 OPEN AIRWAY DENTAL SOLUTIONS LTD. 185
TABLE 172 OPEN AIRWAY DENTAL SOLUTIONS LTD.: BUSINESS OVERVIEW 185
15.1.7 PANTHERA DENTAL 187
TABLE 173 PANTHERA DENTAL: BUSINESS OVERVIEW 187
15.1.8 AIRWAY MANAGEMENT 189
TABLE 174 AIRWAY MANAGEMENT: BUSINESS OVERVIEW 189
15.1.9 APNEA SCIENCES 190
TABLE 175 APNEA SCIENCES: BUSINESS OVERVIEW 190
15.1.10 DYNAFLEX 191
TABLE 176 DYNAFLEX: BUSINESS OVERVIEW 191
15.1.11 ORAVANOSA 192
TABLE 177 ORAVANOSA: BUSINESS OVERVIEW 192
15.1.12 MYERSON LLC 193
TABLE 178 MYERSON LLC: BUSINESS OVERVIEW 193
*Details on Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses & competitive threats might not be captured in case of unlisted companies.
15.2 OTHER PLAYERS 194
15.2.1 MPOWRX HEALTH & WELLNESS 194
15.2.2 THE SNORE RELIEVER COMPANY, LLC 194
15.2.3 THE PURE SLEEP COMPANY 195
15.2.4 TOMED GMBH 195
15.2.5 THE AURUM GROUP 196
15.2.6 ERKODENT ERICH KOPP GMBH 196
15.2.7 OSCIMED SA 197
15.2.8 SICAT GMBH & CO. KG 197
15.2.9 GLIDEWELL 198
15.2.10 APNOMED 198
15.2.11 ZYPPAH 199
15.2.12 DREAM SYSTEMS DENTAL SLEEP LABORATORY 199
15.2.13 ALIVE MED 200
16 APPENDIX 201
16.1 DISCUSSION GUIDE 201
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 205
16.3 CUSTOMIZATION OPTIONS 207
16.4 RELATED REPORTS 207
16.5 AUTHOR DETAILS 208
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/